Payment overview · 2025
General Payments
$330.18
13 reported records · 6 companies
Healthcare provider profile · identity verified
Jerry Warren Whetzel, MD
Allopathic & Osteopathic Physicians|Family Medicine · MUNCIE, IN · NPI 1215935705
Verified facts
What the public records show
CMS Open Payments records show Jerry Warren Whetzel, MD received $330.18 in general payments during 2025 across 13 reported records.
Kerecis Limited accounted for 52.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 8 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 169 claims for Jardiance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Kerecis Limited | Unresolved — no canonical attribution shown | $172.50 | 52.2% | 7 | 2025 |
| Organogenesis Inc. | Unresolved — no canonical attribution shown | $62.25 | 18.9% | 2 | 2025 |
| ConvaTec Inc. | Unresolved — no canonical attribution shown | $42.82 | 13.0% | 1 | 2025 |
| Urgo Medical North America, LLC | Unresolved — no canonical attribution shown | $19.37 | 5.9% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $18.85 | 5.7% | 1 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $14.39 | 4.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $311.33 | 12 |
| Education | $18.85 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $172.50 | 7 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $172.50 | 7 | 2025 |
Source payment records
|
|||||
| INNOVAMATRIX AC Normalized: innovamatrix ac |
Device | ConvaTec Inc. | $42.82 | 1 | 2025 |
Source payment records
|
|||||
| PURAPLY WOUND MATRIX Normalized: puraply wound matrix |
Device | Organogenesis Inc. | $31.59 | 1 | 2025 |
Source payment records
|
|||||
| APLIGRAF Normalized: apligraf |
Device | Organogenesis Inc. | $30.66 | 1 | 2025 |
Source payment records
|
|||||
| VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP Normalized: vashe wound solution 250 ml 8 5 fl oz flip top cap |
Device | Urgo Medical North America, LLC | $19.37 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $18.85 | 1 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $14.39 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 169 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
169 | 33 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1947 | 289 |
| Amlodipine Besylate | Amlodipine Besylate | 1033 | 155 |
| Lisinopril | Lisinopril | 739 | 121 |
| Pantoprazole Sodium | Pantoprazole Sodium | 634 | 93 |
| Levothyroxine Sodium | Levothyroxine Sodium | 584 | 99 |
| Tamsulosin Hcl | Tamsulosin Hcl | 567 | 77 |
| Metformin Hcl | Metformin Hcl | 560 | 104 |
| Furosemide | Furosemide | 542 | 73 |
| Sertraline Hcl | Sertraline Hcl | 467 | 50 |
| Gabapentin | Gabapentin | 406 | 74 |
| Donepezil Hcl | Donepezil Hcl | 394 | 20 |
| Omeprazole | Omeprazole | 393 | 81 |
| Metoprolol Succinate | Metoprolol Succinate | 371 | 66 |
| Potassium Chloride | Potassium Chloride | 336 | 42 |
| Losartan Potassium | Losartan Potassium | 320 | 65 |
| Escitalopram Oxalate | Escitalopram Oxalate | 306 | 27 |
| Eliquis | Apixaban | 293 | 41 |
| Torsemide | Torsemide | 275 | 30 |
| Quetiapine Fumarate | Quetiapine Fumarate | 262 | 13 |
| Mirtazapine | Mirtazapine | 249 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 234 | 52 |
| Carvedilol | Carvedilol | 231 | 50 |
| Levetiracetam | Levetiracetam | 225 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 216 | 76 |
| Pravastatin Sodium | Pravastatin Sodium | 216 | 49 |
| Clopidogrel | Clopidogrel Bisulfate | 208 | 30 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 202 | 50 |
| Tramadol Hcl | Tramadol Hcl | 170 | 28 |
| Jardiance | Empagliflozin | 169 | 33 |
| Allopurinol | Allopurinol | 168 | 28 |
| Alendronate Sodium | Alendronate Sodium | 161 | 48 |
| Montelukast Sodium | Montelukast Sodium | 156 | 29 |
| Memantine Hcl | Memantine Hcl | 151 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 150 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 142 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 126 | 32 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 123 | 21 |
| Meloxicam | Meloxicam | 119 | 27 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 118 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 118 | 36 |
| Myrbetriq | Mirabegron | 115 | suppressed |
| Pregabalin | Pregabalin | 111 | 21 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 107 | 28 |
| Famotidine | Famotidine | 105 | 25 |
| Prednisone | Prednisone | 103 | 69 |
| Glimepiride | Glimepiride | 97 | 19 |
| Warfarin Sodium | Warfarin Sodium | 95 | 20 |
| Risperidone | Risperidone | 92 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 89 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 86 | 15 |
| Lovastatin | Lovastatin | 86 | 20 |
| Simvastatin | Simvastatin | 86 | 20 |
| Oxybutynin Chloride | Oxybutynin Chloride | 83 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 80 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 75 | 21 |
| Finasteride | Finasteride | 73 | 17 |
| Alprazolam | Alprazolam | 69 | 13 |
| Ezetimibe | Ezetimibe | 67 | 21 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 66 | 18 |
| Ondansetron Hcl | Ondansetron Hcl | 66 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 65 | suppressed |
| Trulicity | Dulaglutide | 65 | 13 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 64 | 11 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 64 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 63 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 62 | 17 |
| Spiriva Handihaler | Tiotropium Bromide | 62 | 14 |
| Divalproex Sodium | Divalproex Sodium | 61 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 60 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 60 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 60 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 60 | suppressed |
| Spironolactone | Spironolactone | 57 | 16 |
| Breo Ellipta | Fluticasone/Vilanterol | 55 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 55 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 55 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 54 | 12 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 54 | 41 |
| Humalog Kwikpen U-100 | Insulin Lispro | 54 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 53 | 12 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 53 | suppressed |
| Ozempic | Semaglutide | 53 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 53 | 15 |
| Topiramate | Topiramate | 53 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 52 | suppressed |
| Ranolazine Er | Ranolazine | 52 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 52 | suppressed |
| Loperamide | Loperamide Hcl | 51 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 48 | 13 |
| Nateglinide | Nateglinide | 48 | suppressed |
| Cephalexin | Cephalexin | 47 | 33 |
| Fluticasone Propionate | Fluticasone Propionate | 46 | 17 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 45 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 45 | suppressed |
| Cimetidine | Cimetidine | 44 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 44 | 34 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 44 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 44 | suppressed |
| Indapamide | Indapamide | 43 | 12 |
| Nuplazid | Pimavanserin Tartrate | 43 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 42 | suppressed |
| Colchicine | Colchicine | 42 | suppressed |
| Lorazepam | Lorazepam | 42 | 16 |
| Amoxicillin | Amoxicillin | 40 | 32 |
| Fluoxetine Hcl | Fluoxetine Hcl | 40 | 12 |
| Synthroid | Levothyroxine Sodium | 39 | 11 |
| Fluconazole | Fluconazole | 37 | 19 |
| Lactulose | Lactulose | 37 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 36 | 12 |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 35 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 34 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 33 | suppressed |
| Glipizide | Glipizide | 33 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 33 | suppressed |
| Humalog | Insulin Lispro | 32 | suppressed |
| Nitroglycerin | Nitroglycerin | 31 | 20 |
| Propranolol Hcl Er | Propranolol Hcl | 31 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 31 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 31 | suppressed |
| Atenolol | Atenolol | 30 | suppressed |
| Cilostazol | Cilostazol | 30 | suppressed |
| Folic Acid | Folic Acid | 30 | suppressed |
| Acyclovir | Acyclovir | 29 | 13 |
| Baclofen | Baclofen | 29 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 29 | suppressed |
| Verapamil Er | Verapamil Hcl | 29 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 28 | 25 |
| Nortriptyline Hcl | Nortriptyline Hcl | 28 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 27 | 24 |
| Cholestyramine Light | Cholestyramine | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 25 |
| Nystatin | Nystatin | 27 | 16 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 26 | suppressed |
| Xarelto | Rivaroxaban | 26 | suppressed |
| Azithromycin | Azithromycin | 25 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 25 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | 15 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 23 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 23 | 23 |
| Chlorthalidone | Chlorthalidone | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 15 |
| Novolog Flexpen | Insulin Aspart | 23 | suppressed |
| Rybelsus | Semaglutide | 23 | suppressed |
| Glipizide Er | Glipizide | 22 | suppressed |
| Primidone | Primidone | 22 | suppressed |
| Ramipril | Ramipril | 22 | suppressed |
| Imatinib Mesylate | Imatinib Mesylate | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 19 | suppressed |
| Estradiol | Estradiol | 18 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | 13 |
| Olanzapine | Olanzapine | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Constulose | Lactulose | 16 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 13 |
| Meclizine Hcl | Meclizine Hcl | 16 | 12 |
| Trimethoprim | Trimethoprim | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Klor-Con M20 | Potassium Chloride | 15 | suppressed |
| Movantik | Naloxegol Oxalate | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Repatha Syringe | Evolocumab | 13 | suppressed |
| Sulindac | Sulindac | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 12 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Celecoxib | Celecoxib | 11 | suppressed |
| Desloratadine | Desloratadine | 11 | suppressed |
| Epinephrine | Epinephrine | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $330.18 · 13 records | Kerecis Limited | APLIGRAF, COLLAGENASE SANTYL, INNOVAMATRIX AC, JARDIANCE, Kerecis GraftGuide, Kerecis SurgiClose, PURAPLY WOUND MATRIX, VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error